Concepts (292)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burkholderia pseudomallei | 24 | 2025 | 40 | 4.180 |
Why?
|
| Coxiella burnetii | 10 | 2024 | 16 | 3.330 |
Why?
|
| Phylogeny | 47 | 2025 | 769 | 3.300 |
Why?
|
| Leptospira | 9 | 2025 | 27 | 3.210 |
Why?
|
| Leptospirosis | 9 | 2025 | 31 | 3.170 |
Why?
|
| Genome, Bacterial | 27 | 2020 | 139 | 2.950 |
Why?
|
| Staphylococcus aureus | 8 | 2025 | 94 | 2.850 |
Why?
|
| Melioidosis | 16 | 2025 | 27 | 2.570 |
Why?
|
| Staphylococcal Infections | 6 | 2025 | 67 | 2.490 |
Why?
|
| Genetic Variation | 14 | 2025 | 430 | 2.390 |
Why?
|
| Bacillus anthracis | 20 | 2017 | 33 | 1.940 |
Why?
|
| Q Fever | 5 | 2016 | 7 | 1.640 |
Why?
|
| Polymorphism, Single Nucleotide | 29 | 2019 | 863 | 1.630 |
Why?
|
| DNA, Bacterial | 28 | 2024 | 206 | 1.590 |
Why?
|
| Sequence Analysis, DNA | 23 | 2021 | 515 | 1.480 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2023 | 67 | 1.460 |
Why?
|
| Carrier State | 5 | 2025 | 33 | 1.200 |
Why?
|
| Anthrax | 11 | 2015 | 18 | 1.180 |
Why?
|
| Zoonoses | 4 | 2017 | 21 | 1.170 |
Why?
|
| Evolution, Molecular | 12 | 2018 | 307 | 1.090 |
Why?
|
| Genomics | 6 | 2018 | 293 | 1.080 |
Why?
|
| Genotype | 27 | 2025 | 800 | 0.930 |
Why?
|
| Rural Population | 4 | 2024 | 373 | 0.810 |
Why?
|
| Common Cold | 1 | 2023 | 5 | 0.800 |
Why?
|
| Milk | 4 | 2019 | 56 | 0.800 |
Why?
|
| Cattle Diseases | 3 | 2016 | 30 | 0.710 |
Why?
|
| Rivers | 1 | 2021 | 51 | 0.660 |
Why?
|
| Soil | 2 | 2022 | 171 | 0.640 |
Why?
|
| Genes, Bacterial | 8 | 2015 | 91 | 0.630 |
Why?
|
| Humans | 58 | 2025 | 43102 | 0.630 |
Why?
|
| Metagenome | 1 | 2019 | 31 | 0.620 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2019 | 6 | 0.590 |
Why?
|
| Animals | 33 | 2025 | 16992 | 0.590 |
Why?
|
| Educational Status | 1 | 2020 | 339 | 0.580 |
Why?
|
| Orientia tsutsugamushi | 1 | 2018 | 7 | 0.580 |
Why?
|
| Disease Outbreaks | 7 | 2015 | 175 | 0.540 |
Why?
|
| Adenoma | 1 | 2019 | 96 | 0.540 |
Why?
|
| Molecular Epidemiology | 13 | 2015 | 59 | 0.530 |
Why?
|
| Cholera | 3 | 2014 | 74 | 0.530 |
Why?
|
| Gene Transfer, Horizontal | 3 | 2018 | 24 | 0.520 |
Why?
|
| False Positive Reactions | 2 | 2016 | 28 | 0.520 |
Why?
|
| Cattle | 7 | 2017 | 498 | 0.500 |
Why?
|
| Poverty | 2 | 2017 | 400 | 0.500 |
Why?
|
| Ecuador | 4 | 2024 | 14 | 0.480 |
Why?
|
| Minisatellite Repeats | 7 | 2010 | 18 | 0.470 |
Why?
|
| Bacterial Typing Techniques | 11 | 2016 | 37 | 0.420 |
Why?
|
| Vibrio cholerae | 2 | 2011 | 105 | 0.420 |
Why?
|
| Classification | 1 | 2013 | 9 | 0.400 |
Why?
|
| Soil Microbiology | 5 | 2021 | 68 | 0.400 |
Why?
|
| Arizona | 4 | 2023 | 139 | 0.390 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 512 | 0.390 |
Why?
|
| Genetics, Population | 2 | 2011 | 121 | 0.380 |
Why?
|
| Disease Reservoirs | 3 | 2025 | 25 | 0.380 |
Why?
|
| DNA Fingerprinting | 2 | 2009 | 16 | 0.380 |
Why?
|
| Polymerase Chain Reaction | 8 | 2012 | 455 | 0.360 |
Why?
|
| Prevalence | 4 | 2023 | 1612 | 0.360 |
Why?
|
| Burkholderia mallei | 4 | 2014 | 6 | 0.330 |
Why?
|
| Australia | 7 | 2018 | 103 | 0.330 |
Why?
|
| Goats | 3 | 2019 | 23 | 0.330 |
Why?
|
| DNA, Ribosomal | 2 | 2021 | 39 | 0.260 |
Why?
|
| Female | 14 | 2025 | 24698 | 0.260 |
Why?
|
| Geography | 7 | 2011 | 110 | 0.250 |
Why?
|
| Tularemia | 3 | 2014 | 115 | 0.250 |
Why?
|
| Recombination, Genetic | 2 | 2018 | 95 | 0.250 |
Why?
|
| Francisella tularensis | 3 | 2014 | 116 | 0.250 |
Why?
|
| Dogs | 4 | 2024 | 204 | 0.240 |
Why?
|
| Sputum | 1 | 2025 | 22 | 0.230 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2024 | 203 | 0.230 |
Why?
|
| Rodent Diseases | 1 | 2025 | 13 | 0.230 |
Why?
|
| Burkholderia | 2 | 2016 | 17 | 0.230 |
Why?
|
| Endemic Diseases | 2 | 2024 | 23 | 0.220 |
Why?
|
| Computational Biology | 3 | 2019 | 327 | 0.220 |
Why?
|
| High-Throughput Screening Assays | 1 | 2025 | 74 | 0.220 |
Why?
|
| Cluster Analysis | 10 | 2015 | 207 | 0.220 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2016 | 27 | 0.210 |
Why?
|
| Dog Diseases | 1 | 2024 | 49 | 0.210 |
Why?
|
| Software | 2 | 2019 | 236 | 0.210 |
Why?
|
| Glanders | 3 | 2014 | 4 | 0.210 |
Why?
|
| Models, Genetic | 3 | 2018 | 183 | 0.210 |
Why?
|
| Male | 12 | 2025 | 23409 | 0.210 |
Why?
|
| Sensitivity and Specificity | 4 | 2021 | 611 | 0.210 |
Why?
|
| Nasal Cavity | 1 | 2023 | 10 | 0.200 |
Why?
|
| Base Sequence | 8 | 2012 | 983 | 0.200 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 3156 | 0.200 |
Why?
|
| Middle Aged | 7 | 2020 | 12222 | 0.190 |
Why?
|
| Bacteriological Techniques | 2 | 2012 | 15 | 0.190 |
Why?
|
| Mexico | 1 | 2023 | 298 | 0.180 |
Why?
|
| Rats | 3 | 2025 | 3735 | 0.180 |
Why?
|
| Species Specificity | 6 | 2014 | 286 | 0.180 |
Why?
|
| Risk Factors | 2 | 2020 | 3994 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 4 | 2020 | 432 | 0.170 |
Why?
|
| Ixodes | 1 | 2021 | 3 | 0.170 |
Why?
|
| United States | 7 | 2017 | 5205 | 0.170 |
Why?
|
| Longitudinal Studies | 2 | 2025 | 1063 | 0.170 |
Why?
|
| Yersinia pestis | 2 | 2014 | 35 | 0.170 |
Why?
|
| Molecular Sequence Data | 10 | 2013 | 1542 | 0.160 |
Why?
|
| Swine | 2 | 2022 | 212 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 694 | 0.160 |
Why?
|
| Symbiosis | 1 | 2020 | 46 | 0.160 |
Why?
|
| Metagenomics | 1 | 2019 | 46 | 0.150 |
Why?
|
| Water Microbiology | 2 | 2017 | 81 | 0.150 |
Why?
|
| Biological Warfare Agents | 2 | 2017 | 4 | 0.150 |
Why?
|
| Gene Duplication | 1 | 2018 | 24 | 0.140 |
Why?
|
| DNA Primers | 4 | 2012 | 294 | 0.140 |
Why?
|
| Feces | 1 | 2019 | 132 | 0.140 |
Why?
|
| Mice | 3 | 2020 | 6644 | 0.140 |
Why?
|
| Ascomycota | 1 | 2017 | 21 | 0.140 |
Why?
|
| Mycoses | 1 | 2017 | 31 | 0.130 |
Why?
|
| Chiroptera | 1 | 2017 | 25 | 0.130 |
Why?
|
| Mutation | 5 | 2024 | 1177 | 0.130 |
Why?
|
| Horses | 2 | 2014 | 28 | 0.130 |
Why?
|
| Sequence Alignment | 2 | 2016 | 272 | 0.130 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2016 | 90 | 0.130 |
Why?
|
| Deer | 1 | 2017 | 16 | 0.130 |
Why?
|
| Dairying | 1 | 2016 | 3 | 0.130 |
Why?
|
| Communicable Diseases, Emerging | 2 | 2017 | 14 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2020 | 549 | 0.120 |
Why?
|
| Klebsiella Infections | 1 | 2016 | 11 | 0.120 |
Why?
|
| Transportation | 1 | 2016 | 27 | 0.120 |
Why?
|
| Klebsiella pneumoniae | 1 | 2016 | 26 | 0.120 |
Why?
|
| Coxiella | 1 | 2016 | 3 | 0.120 |
Why?
|
| Ticks | 1 | 2016 | 8 | 0.120 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 1234 | 0.120 |
Why?
|
| Cross Infection | 1 | 2016 | 48 | 0.120 |
Why?
|
| Plague | 2 | 2014 | 25 | 0.120 |
Why?
|
| Databases, Genetic | 3 | 2016 | 103 | 0.120 |
Why?
|
| Adaptation, Biological | 2 | 2013 | 29 | 0.120 |
Why?
|
| Databases, Factual | 2 | 2019 | 341 | 0.110 |
Why?
|
| Bayes Theorem | 2 | 2015 | 126 | 0.110 |
Why?
|
| Regression Analysis | 1 | 2016 | 490 | 0.110 |
Why?
|
| Papua New Guinea | 2 | 2011 | 21 | 0.110 |
Why?
|
| Vibrio cholerae O1 | 1 | 2014 | 11 | 0.110 |
Why?
|
| Base Pair Mismatch | 2 | 2012 | 15 | 0.110 |
Why?
|
| Sheep Diseases | 1 | 2014 | 4 | 0.110 |
Why?
|
| Electrophoresis, Capillary | 2 | 2012 | 20 | 0.110 |
Why?
|
| Brucellaceae | 1 | 2013 | 1 | 0.110 |
Why?
|
| Georgia | 1 | 2014 | 192 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2020 | 719 | 0.100 |
Why?
|
| beta-Lactamases | 1 | 2013 | 34 | 0.100 |
Why?
|
| Burkholderia Infections | 1 | 2013 | 3 | 0.100 |
Why?
|
| Europe | 4 | 2017 | 115 | 0.100 |
Why?
|
| Escherichia coli Infections | 1 | 2013 | 45 | 0.100 |
Why?
|
| Sequence Homology | 2 | 2009 | 35 | 0.100 |
Why?
|
| Bioterrorism | 3 | 2008 | 20 | 0.100 |
Why?
|
| Brucella melitensis | 1 | 2012 | 1 | 0.090 |
Why?
|
| Brucella suis | 1 | 2012 | 1 | 0.090 |
Why?
|
| Brucella abortus | 1 | 2012 | 4 | 0.090 |
Why?
|
| Heroin | 1 | 2012 | 18 | 0.090 |
Why?
|
| Virulence | 4 | 2015 | 246 | 0.090 |
Why?
|
| Ceftazidime | 1 | 2012 | 2 | 0.090 |
Why?
|
| Methicillin Resistance | 1 | 2012 | 12 | 0.090 |
Why?
|
| DNA, Ribosomal Spacer | 1 | 2011 | 5 | 0.090 |
Why?
|
| Asia, Southeastern | 1 | 2011 | 12 | 0.090 |
Why?
|
| Cryptococcus gattii | 1 | 2011 | 8 | 0.090 |
Why?
|
| Population Dynamics | 2 | 2025 | 50 | 0.090 |
Why?
|
| Chromosome Inversion | 1 | 2011 | 9 | 0.090 |
Why?
|
| Mass Screening | 1 | 2016 | 541 | 0.090 |
Why?
|
| Animal Structures | 1 | 2011 | 22 | 0.090 |
Why?
|
| Recreation | 1 | 2011 | 43 | 0.090 |
Why?
|
| Incidental Findings | 1 | 2011 | 12 | 0.090 |
Why?
|
| Gene Frequency | 1 | 2011 | 206 | 0.090 |
Why?
|
| Cryptococcosis | 1 | 2011 | 43 | 0.090 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2012 | 129 | 0.090 |
Why?
|
| Pneumonia | 1 | 2011 | 61 | 0.080 |
Why?
|
| Escherichia coli | 1 | 2013 | 460 | 0.080 |
Why?
|
| DNA, Mitochondrial | 1 | 2012 | 191 | 0.080 |
Why?
|
| Asia | 3 | 2017 | 98 | 0.080 |
Why?
|
| Brucella | 1 | 2009 | 5 | 0.070 |
Why?
|
| Forensic Sciences | 2 | 2008 | 2 | 0.070 |
Why?
|
| Virulence Factors | 3 | 2016 | 125 | 0.070 |
Why?
|
| Bacteria | 1 | 2012 | 293 | 0.070 |
Why?
|
| Mammals | 2 | 2024 | 112 | 0.070 |
Why?
|
| Adult | 4 | 2020 | 13872 | 0.070 |
Why?
|
| Algorithms | 1 | 2011 | 509 | 0.070 |
Why?
|
| North America | 3 | 2017 | 85 | 0.070 |
Why?
|
| Tandem Repeat Sequences | 1 | 2007 | 10 | 0.070 |
Why?
|
| Bacterial Proteins | 5 | 2013 | 595 | 0.070 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 3 | 2013 | 27 | 0.060 |
Why?
|
| Ape Diseases | 1 | 2006 | 4 | 0.060 |
Why?
|
| Aged | 1 | 2019 | 8214 | 0.060 |
Why?
|
| Boston | 1 | 2025 | 32 | 0.060 |
Why?
|
| Animals, Domestic | 1 | 2024 | 11 | 0.060 |
Why?
|
| Mouth | 1 | 2025 | 54 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2012 | 245 | 0.050 |
Why?
|
| Animals, Wild | 1 | 2024 | 24 | 0.050 |
Why?
|
| Guinea Pigs | 1 | 2024 | 143 | 0.050 |
Why?
|
| Ciprofloxacin | 1 | 2003 | 16 | 0.050 |
Why?
|
| Nepal | 2 | 2014 | 19 | 0.050 |
Why?
|
| Spleen | 1 | 2024 | 204 | 0.050 |
Why?
|
| Reproduction | 1 | 2024 | 94 | 0.050 |
Why?
|
| Haiti | 2 | 2014 | 86 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2003 | 100 | 0.050 |
Why?
|
| Ecosystem | 1 | 2024 | 175 | 0.050 |
Why?
|
| Environmental Microbiology | 2 | 2016 | 27 | 0.050 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 75 | 0.050 |
Why?
|
| Kidney | 1 | 2025 | 372 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 239 | 0.050 |
Why?
|
| Biodiversity | 2 | 2013 | 111 | 0.040 |
Why?
|
| Genetic Markers | 2 | 2016 | 150 | 0.040 |
Why?
|
| Arthropod Vectors | 1 | 2021 | 2 | 0.040 |
Why?
|
| Northwestern United States | 1 | 2021 | 6 | 0.040 |
Why?
|
| Tick Infestations | 1 | 2021 | 4 | 0.040 |
Why?
|
| Climate | 1 | 2021 | 22 | 0.040 |
Why?
|
| DNA | 1 | 2024 | 592 | 0.040 |
Why?
|
| Lyme Disease | 1 | 2021 | 28 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2012 | 64 | 0.040 |
Why?
|
| Seasons | 1 | 2021 | 139 | 0.040 |
Why?
|
| Climate Change | 1 | 2021 | 53 | 0.040 |
Why?
|
| Alleles | 2 | 2012 | 352 | 0.040 |
Why?
|
| Chromosomes, Bacterial | 2 | 2012 | 21 | 0.040 |
Why?
|
| Inhalation Exposure | 2 | 2011 | 44 | 0.040 |
Why?
|
| Water | 1 | 2022 | 316 | 0.040 |
Why?
|
| Australasia | 1 | 2018 | 3 | 0.040 |
Why?
|
| New Guinea | 1 | 2018 | 5 | 0.040 |
Why?
|
| History, Ancient | 1 | 2018 | 13 | 0.040 |
Why?
|
| California | 1 | 2021 | 548 | 0.040 |
Why?
|
| Mutation, Missense | 2 | 2013 | 91 | 0.040 |
Why?
|
| Public Health | 1 | 2022 | 424 | 0.030 |
Why?
|
| Nose | 1 | 2017 | 11 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 2017 | 61 | 0.030 |
Why?
|
| Thailand | 2 | 2007 | 51 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2022 | 1413 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 9 | 0.030 |
Why?
|
| Housing, Animal | 1 | 2016 | 12 | 0.030 |
Why?
|
| Taq Polymerase | 2 | 2006 | 8 | 0.030 |
Why?
|
| Indiana | 1 | 2015 | 17 | 0.030 |
Why?
|
| Drug Users | 1 | 2015 | 52 | 0.030 |
Why?
|
| Bahrain | 1 | 2014 | 2 | 0.030 |
Why?
|
| Hungary | 1 | 2014 | 9 | 0.030 |
Why?
|
| History, Medieval | 1 | 2014 | 4 | 0.030 |
Why?
|
| Sheep | 1 | 2014 | 77 | 0.030 |
Why?
|
| Tooth | 1 | 2014 | 11 | 0.030 |
Why?
|
| Polymorphism, Genetic | 2 | 2005 | 201 | 0.030 |
Why?
|
| Germany | 1 | 2013 | 26 | 0.030 |
Why?
|
| Africa | 1 | 2014 | 82 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2013 | 4 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2013 | 23 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2014 | 119 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2013 | 93 | 0.020 |
Why?
|
| Brucellosis | 1 | 2012 | 8 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2013 | 171 | 0.020 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2012 | 9 | 0.020 |
Why?
|
| Exhumation | 1 | 2012 | 1 | 0.020 |
Why?
|
| Utah | 1 | 2012 | 10 | 0.020 |
Why?
|
| Spores, Bacterial | 1 | 2012 | 9 | 0.020 |
Why?
|
| Base Composition | 1 | 2012 | 26 | 0.020 |
Why?
|
| Methicillin | 1 | 2012 | 4 | 0.020 |
Why?
|
| History, 19th Century | 1 | 2012 | 25 | 0.020 |
Why?
|
| Tetracycline | 1 | 2012 | 17 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2012 | 56 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 95 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 53 | 0.020 |
Why?
|
| Food Microbiology | 1 | 2012 | 39 | 0.020 |
Why?
|
| Genome, Fungal | 1 | 2011 | 28 | 0.020 |
Why?
|
| Operon | 1 | 2011 | 43 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2012 | 40 | 0.020 |
Why?
|
| Bacteriophages | 1 | 2012 | 44 | 0.020 |
Why?
|
| Georgia (Republic) | 1 | 2011 | 1 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2012 | 114 | 0.020 |
Why?
|
| Population Groups | 1 | 2011 | 59 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 179 | 0.020 |
Why?
|
| Genome | 1 | 2011 | 149 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 780 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 238 | 0.020 |
Why?
|
| Pakistan | 1 | 2009 | 20 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 196 | 0.020 |
Why?
|
| Ochrobactrum anthropi | 1 | 2009 | 1 | 0.020 |
Why?
|
| Microbiological Techniques | 1 | 2008 | 14 | 0.020 |
Why?
|
| China | 1 | 2009 | 229 | 0.020 |
Why?
|
| Russia | 1 | 2008 | 29 | 0.020 |
Why?
|
| Synteny | 1 | 2007 | 19 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2008 | 50 | 0.020 |
Why?
|
| Multigene Family | 1 | 2007 | 105 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 712 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2008 | 144 | 0.020 |
Why?
|
| Gorilla gorilla | 1 | 2006 | 4 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 1081 | 0.020 |
Why?
|
| Molecular Probe Techniques | 1 | 2006 | 7 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 2006 | 20 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 423 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2006 | 75 | 0.020 |
Why?
|
| Texas | 1 | 2008 | 457 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 704 | 0.020 |
Why?
|
| Nucleotides | 1 | 2005 | 37 | 0.010 |
Why?
|
| Hypertension | 1 | 2011 | 835 | 0.010 |
Why?
|
| Child | 1 | 2011 | 3443 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 760 | 0.010 |
Why?
|
| Obesity | 1 | 2011 | 1151 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2003 | 91 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2003 | 321 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 5080 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 6081 | 0.010 |
Why?
|